A new primate study finds evidence that growth factor plays a key role in maintaining healthy pregnancy by promoting artery remodeling.
A University of Maryland School of Medicine study suggests that a novel machine learning model developed at the University of Maryland Medical System (UMMS), called the Baltimore score (B score), may help hospitals better predict which discharged patients are likely to be readmitted.
Researchers analyzed biomarkers secreted from transplanted human stem cells in the recipient blood of a rodent model of heart attack. Analysis of the blood test showed responding cells had changed their gene expression, behavior and secretions, suggesting this liquid biopsy could provide a window into stem cell activity and effectiveness.
In a first-ever advancement in human medicine and aviation technology, a University of Maryland unmanned aircraft has delivered a donor kidney to surgeons at the University of Maryland Medical Center in Baltimore for successful transplantation into a patient with kidney failure. This successful demonstration illustrates the potential of unmanned aircraft systems (UAS) for providing organ deliveries that, in many cases, could be faster, safer, and more widely available than traditional transport methods. The momentous flight was a collaboration between transplant physicians and researchers at the University of Maryland School of Medicine in Baltimore; aviation and engineering experts at the University of Maryland; the University of Maryland Medical Center; and collaborators at the Living Legacy Foundation of Maryland.
A University of Maryland Medicine team performed a rare bilateral lung-heart transplant on a 12-year-old girl. The surgery was done at the University of Maryland Children’s Hospital.
University of Maryland School of Medicine (UMSOM) surgeons have identified a group of lymph nodes in the chest that appear highly significant in predicting the prognosis for patients with malignant pleural mesothelioma – a deadly cancer of the chest lining that is usually caused by asbestos. The researchers found that the presence of cancer in these lymph nodes increased the risk of recurrence or death more than two-fold in patients undergoing surgery for mesothelioma, according to new research presented recently week at the Society of Thoracic Surgeons (STS) annual meeting in San Diego, Calif.
Radiation oncologists at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) are now treating patients with the GammaPod™, a new FDA-cleared radiation therapy for early-stage breast cancer. The UMGCCC is the first site to treat patients with this first-of-its-kind system, which was invented by University of Maryland School of Medicine (UMSOM) scientists and physicians. This is the only external-beam radiation delivery system specifically designed to treat breast cancer.
University of Maryland physician-scientists have treated the first patient in the United States with MRI-guided focused ultrasound for neuropathic leg pain as part of a pilot clinical trial.
The Maryland Proton Treatment Center (MPTC) is now offering deep-tissue external thermal therapy in combination with high-precision proton-beam radiotherapy as a potential way to boost survival chances for certain cancer patients. MPTC is the only center in the world to offer these two treatments at the same facility, an advantage to patients because these therapies are typically given within an hour of each other.
The pediatric intensive care unit (PICU) team at the University of Maryland Children’s Hospital (UMCH) is offering a new way for families to interact with their child and the medical team when they can’t be there in person. PICU Connect is a mobile cart fashioned with a computer, speaker and 180-degree camera. It allows family members who cannot be at their child’s hospital bedside to feel like they are in the room. The technology uses high-quality, real-time video and audio, and links up through a person’s phone, tablet or computer. The family member can clearly see, listen and talk with the child and care team, so they aren’t missing important discussions about the child’s care plan. It is HIPAA-compliant, which means it meets federal patient privacy law requirements. The video sessions cannot be recorded or intercepted, and disappear once they are over.
The Hypertrophic Cardiomyopathy Program at the University of Maryland Heart & Vascular Center (UMHVC) has been recognized as a Center of Excellence by the Hypertrophic Cardiomyopathy Association (HCMA) – one of about 30 Centers of Excellence nationwide and the only HCMA-recognized center in Maryland.
At a time when drug overdoses are becoming more prevalent and lethal, a new report provides a snapshot of regional illicit drug use and, for the first time, highlights the complexity of detecting and treating patients at hospital emergency departments for a severe drug-related event.
In the first such clinical trial in the United States, physician-scientists with the University of Maryland School of Medicine (UMSOM) are investigating the use of MRI-guided focused ultrasound to open the blood-brain barrier. The trial will be conducted with patients undergoing brain cancer surgery at the University of Maryland Medical Center (UMMC).
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) joins with 69 other National Cancer Institute (NCI)-designated cancer centers to urge increased vaccination for human papillomavirus (HPV) and screening to eliminate HPV-related cancers.
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is now certified to offer a groundbreaking treatment for non-Hodgkin lymphoma, in which a patient’s own immune cells are genetically engineered to recognize and attack the cancer.
The University of Maryland Medical Center (UMMC) and the University of Maryland School of Medicine (UMSOM)) are leading a phase 3 study to test the safety and efficacy of using MRI-guided focused ultrasound on the brain in order to treat Parkinson’s disease. The pivotal study is the final step before the U.S. Food and Drug Administration (FDA) will consider approving the new technology for widespread use as a nonsurgical treatment option to eliminate key motor symptoms of this common neurological condition.
Researchers at the University of Maryland School of Medicine have uncovered genetic mutations that may explain why people with high levels of high-density lipoprotein (HDL) cholesterol, the “good cholesterol,” have a reduced risk of coronary heart disease.
The GammaPod ™ – a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer – has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.
A clinical trial using genetic testing to match acute myeloid leukemia (AML) patients with new therapies is now open at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). The center is one of seven cancer centers nationwide participating in the Beat AML® Master Trial, sponsored by the Leukemia & Lymphoma Society (LLS).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right